RxDoctor Payments Data

David Stolzenberg, DO

Physical Medicine & Rehabilitation · Bryn Mawr, PANPI 1003050535

Payments from drug & device makers

What this record shows

Relievant Medsystems, Inc. accounts for 78.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $1,544 and has fallen 88.1% since, to $183 in 2025.

$3,330in general payments, 2019–2025

Across 34 payments — averaging $97.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Relievant Medsystems, Inc.$3K
  • Zimmer Biomet$244
  • Medtronic$180
  • Boston Scientific$169
  • Johnson & Johnson$43
  • Abbott$25
  • plus $62 from 3 others
$7,052in research payments, 2019–2025

Across 2 payments — averaging $3526.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Avanos Medical$7K

What the payments were for

  • Travel & lodging$1,55147%
  • Food & beverage$1,78053%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,330 in reported general payments places this provider in the 85th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.

See all physical medicine & rehabilitation providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$390,251
Medicare patients
855
Services billed
26,865

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin419$3,987
Pregabalin108$3,423
Buprenorphine27$2,510
Tizanidine Hcl180$1,830
Celecoxib94$1,601
Methocarbamol46$560
Methylprednisolone83$444
Duloxetine Hcl20$437
Tramadol Hcl140$420
Baclofen30$319
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$308
Meloxicam72$270
Oxycodone Hcl12$218
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32$195
Prednisone65$136

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Bryn Mawr

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →